GLO Science, Inc. amends its claim of patent infringement against Nanchang Dental Bright Company, Ltd.
December 26, 2017 – GLO Science, Inc., the owner of patents D765 255 (‘255) and D636 074 (‘074), filed a…
Recent Posts
Siemens Healthcare Diagnostics Files An Inter Partes Review Petition Against Radiometer Medical APS
December 21, 2017 – Siemens AG, Siemens Healthcare Diagnostics, Inc., Siemens Healthcare GMBH, and Siemens Medical Solutions USA, Inc., collectively,…
Court Granted in Part and Denied in Part Defendant’s Motion to Dismiss Over Unpatentable Subject Matter, Abstract Ideas, and Lack of Inventive Concept
December 21, 2017 – On December 19, 2017, the court granted in part Defendant QuantifiCare Inc.’s motion to dismiss because…
PTAB Grants Cook’s Request for Rehearing
December 19, 2017 – The Patent Trial and Appeal Board (“PTAB”) granted Petitioner Cook Group Inc. and Cook Group Medical…
PTAB Institutes Inter Partes Review of Two B. Braun Melsungen AG Patents
December 19, 2017 – The Patent Trial and Appeal Board (“PTAB”) instituted inter partes review of two B. Braun Melsungen…
Petition for Inter Partes Review by Cook Group Inc. and Cook Medical LLC
On December 18, 2017, the USPTO’s Patent Trial and Appeal Board (“Board”) issued a final decision in an inter partes…
Petition for Inter Partes Review by Smith & Nephew, Inc. and Arthrocare Corp.
On December 15, 2017, the USPTO’s Patent Trial and Appeal Board (“Board”) issued a final decision in an inter partes…
Petition for Inter Partes Review by Minerva Surgical, Inc.
On December 15, 2017, the USPTO’s Patent Trial and Appeal Board (“Board”) issued a final decision in an inter partes…
Petition for Inter Partes Review by Becton, Dickinson and Company
On December 15, 2017, the USPTO’s Patent Trial and Appeal Board (“Board”) issued a final decision in an inter partes…
Mylan Technologies Files Two Inter Partes Review Petitions Against Noven Pharmaceuticals
December 5, 2017 – Mylan Technologies, Inc. filed two inter partes review petitions to invalidate two of Noven Pharmaceuticals, Inc.’s…